bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report)’s share price rose 3% during mid-day trading on Wednesday . The stock traded as high as $99.43 and last traded at $99.43. Approximately 22 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 158 shares. The stock had previously closed at $96.50.
bioMérieux Price Performance
The firm’s 50-day simple moving average is $100.48 and its 200-day simple moving average is $105.98.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Read More
- Five stocks we like better than bioMérieux
- How to Invest in Biotech Stocks
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- What is the S&P/TSX Index?
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- 3 Fintech Stocks With Good 2021 Prospects
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
